Westpac Banking Corp’s Ionis Pharmaceuticals IONS Stock Holding History

Westpac Banking Corp’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,594	Closed	-$476K	–	857
2021 Q1	$476K	Hold	10,594	–	–	0.01%	771
2020 Q4	$599K	Hold	10,594	–	–	0.01%	802
2020 Q3	$503K	Hold	10,594	–	–	0.01%	788
2020 Q2	$625K	Hold	10,594	–	–	0.01%	735
2020 Q1	$501K	Hold	10,594	–	–	0.01%	718
2019 Q4	$640K	Hold	10,594	–	–	0.01%	773
2019 Q3	$635K	Hold	10,594	–	–	0.01%	739
2019 Q2	$681K	Buy	+10,594	New	+$749K	0.01%	621
2016 Q4	–	Sell	-17,716	Closed	-$649K	–	836
2016 Q3	$649K	Sell	17,716 -74,177	-81%	-$2.32M	0.01%	627
2016 Q2	$1.85M	Buy	91,893 +87,663	+2,072%	+$2.83M	0.02%	510
2016 Q1	$171K	Hold	4,230	–	–	﹤0.01%	827
2015 Q4	$262K	Sell	4,230 -984	-19%	-$53.1K	﹤0.01%	788
2015 Q3	$211K	Buy	5,214 +4,458	+590%	+$231K	﹤0.01%	777
2015 Q2	$43.5K	Sell	756 -6,716	-90%	-$427K	﹤0.01%	835
2015 Q1	$541K	Buy	+7,472	New	+$507K	﹤0.01%	738

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Westpac Banking Corp's IONS Position: Q2 2021 in Review

Westpac Banking Corp sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 10,594 shares — an estimated $476K sold.

Westpac Banking Corp first reported a position in IONS in Q1 2015 and held it in 15 quarters. The position peaked at $1.85M in Q2 2016. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Westpac Banking Corp reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Westpac Banking Corp sold 10,594 Ionis Pharmaceuticals shares in Q2 2021, an estimated $476K.
Westpac Banking Corp first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 15 quarters.
Westpac Banking Corp's Ionis Pharmaceuticals position peaked at $1.85M in Q2 2016.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Westpac Banking Corp's 13F filing for Q2 2021, filed 11 Aug 2021.